- Report
- April 2026
- 291 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 456 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 368 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 192 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 258 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 266 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- May 2025
- 236 Pages
Global
From €4252EUR$4,750USD£3,714GBP
- Report
- November 2025
- 150 Pages
Global
From €3357EUR$3,750USD£2,932GBP
- Report
- November 2025
- 150 Pages
Global
From €3357EUR$3,750USD£2,932GBP
- Report
- November 2025
- 150 Pages
Global
From €3357EUR$3,750USD£2,932GBP
- Report
- September 2025
- 186 Pages
Global
From €4028EUR$4,500USD£3,519GBP
- Report
- September 2025
- 189 Pages
Global
From €4028EUR$4,500USD£3,519GBP
- Report
- July 2025
- 350 Pages
Global
From €4430EUR$4,949USD£3,870GBP
- Report
- June 2025
- 400 Pages
Global
From €4430EUR$4,949USD£3,870GBP
- Report
- June 2025
- 400 Pages
Global
From €4430EUR$4,949USD£3,870GBP
- Report
- January 2026
- 181 Pages
Global
From €4028EUR$4,500USD£3,519GBP
- Report
- November 2025
- 146 Pages
Global
From €3536EUR$3,950USD£3,088GBP
- Report
- May 2025
- 147 Pages
Global
From €3536EUR$3,950USD£3,088GBP
- Report
- April 2025
- 155 Pages
Global
From €3536EUR$3,950USD£3,088GBP
- Report
- October 2025
- 150 Pages
Global
From €4341EUR$4,850USD£3,792GBP

The Continuous Glucose Monitoring (CGM) market is a subset of the larger glucose testing market. CGM is a technology that allows for the continuous monitoring of glucose levels in the body. It is typically used by people with diabetes to help them better manage their condition. CGM systems consist of a sensor, transmitter, and receiver. The sensor is inserted under the skin and measures glucose levels in the interstitial fluid. The transmitter sends the data to the receiver, which displays the glucose levels. CGM systems can provide real-time data and alert users when their glucose levels are too high or too low.
Some companies in the CGM market include Dexcom, Abbott, Medtronic, and Senseonics. Show Less Read more